Skip to main content

Table 1 Subject characteristics

From: Dietary changes in migrant adolescents with increasing length of stay in Australia and associated risk of wheeze – a retrospective, cross sectional study

N

144

Agea

13.6 (12.8–15.2)

Sex (%Males)

53.5

BMI (kg/m2)

20.2 (18.1–22.8)

FEV1, L

2.85 (2.40–3.40)

FVC, L (n = 116)

3.18 (2.79–3.80)

FEV1/FVC (n = 116)

0.90 (0.85–0.95)

DRS (%fall/mL)

0.22 (0.07–0.44)

Asthma Symptoms (%Yes)

28.5

Atopy (%Yes)

51.4

Wheeze (%Yes)

24.3

Asthma medication usage (%Yes)b

12.5

Years in Australia

3.0 (0.7–12.3)

Language (%English only)

34.7

  1. BMI Body mass index, FEV1 forced expiratory volume in 1 s; FVC forced vital capacity; DRS dose response slope
  2. aAll data are presented as Median (IQR) unless otherwise stated. bAsthma medications include: Alupent, Asmol, Atrovent, Becloforte, Becotide, Bricanyl, Flixotide, Pulmicorte, Respolin, Serevent, Theophylline, Ventolin